Semmelweis Publications
  • Main page

    • Szebeni, János Semmelweis University affiliated publications (2020-2025)

    Year:
    Order by:
    Authorship:
    Number of publications: 23
    1.
    To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives
    Shi, D;Beasock, D;Fessler, A;Szebeni, J;Ljubimova, JY;Afonin, KA;Dobrovolskaia, MA
    D1
    ADVANCED DRUG DELIVERY REVIEWS
    2022.
    DOI:10.1016/j.addr.2021.114079 (Copy DOI)
    Semmelweis University authors: Szebeni, János,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Transzlációs Medicina Intézet,
    2.
    Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
    Senti, ME;de Jongh, CA;Dijkxhoorn, K;Verhoef, JJF;Szebeni, J;Storm, G;Hack, CE;Schiffelers, RM;Fens, MH;Boross, P
    D1
    JOURNAL OF CONTROLLED RELEASE
    2022.
    DOI:10.1016/j.jconrel.2021.11.042 (Copy DOI)
    Semmelweis University authors: Szebeni, János,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Transzlációs Medicina Intézet,
    3.
    Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
    Kozma, GT;Shimizu, T;Ishida, T;Szebeni, J
    D1
    ADVANCED DRUG DELIVERY REVIEWS
    2020.
    DOI:10.1016/j.addr.2020.07.024 (Copy DOI)
    Semmelweis University authors: Kozma, Gergely Tibor, Szebeni, János,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Transzlációs Medicina Intézet,
    4.
    Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
    Kozma, GT;Mészáros, T;Berényi, P;Facskó, R;Patkó, Z;Oláh, CZ;Nagy, A;Fülöp, TG;Glatter, KA;Radovits, T;Merkely, B;Szebeni, J
    D1
    VACCINE
    2023.
    DOI:10.1016/j.vaccine.2023.06.009 (Copy DOI)
    5.
    mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions
    Bakos, T;Mészáros, T;Kozma, GT;Berényi, P;Facskó, R;Farkas, H;Dézsi, L;Heirman, C;de Koker, S;Schiffelers, R;Glatter, KA;Radovits, T;Szénási, G;Szebeni, J
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2024.
    DOI:10.3390/ijms25073595 (Copy DOI)
    6.
    A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor
    Dézsi, L;Mészáros, T;Kozma, G;H-Velkei, M;Oláh, CZ;Szabó, M;Patkó, Z;Fülöp, T;Hennies, M;Szebeni, M;Barta, BA;Merkely, B;Radovits, T;Szebeni, J
    D1
    GEROSCIENCE
    2022.
    DOI:10.1007/s11357-021-00495-y (Copy DOI)
    7.
    Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA-Lipid Complexes
    Szebeni, J;Kiss, B;Bozó, T;Turjeman, K;Levi-Kalisman, Y;Barenholz, Y;Kellermayer, M
    D1
    ACS NANO
    2023.
    DOI:10.1021/acsnano.2c11904 (Copy DOI)
    8.
    Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
    Szebeni, J;Storm, G;Ljubimova, JY;Castells, M;Phillips, EJ;Turjeman, K;Barenholz, Y;Crommelin, DJA;Dobrovolskaia, MA
    D1
    NATURE NANOTECHNOLOGY
    2022.
    DOI:10.1038/s41565-022-01071-x (Copy DOI)
    Semmelweis University authors: Szebeni, János,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Transzlációs Medicina Intézet,
    9.
    Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety
    Unterweger, H;Janko, C;Folk, T;Cicha, I;Kovács, N;Gyebnár, G;Horváth, I;Máthé, D;Zheng, KH;Coolen, BF;Stroes, E;Szebeni, J;Alexiou, C;Dézsi, L;Lyer, S
    D1
    INTERNATIONAL JOURNAL OF NANOMEDICINE
    2023.
    DOI:10.2147/IJN.S402320 (Copy DOI)
    10.
    Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies
    Barta, BA;Radovits, T;Dobos, AB;Kozma, GT;Mészáros, T;Berényi, P;Facskó, R;Fülöp, T;Merkely, B;Szebeni, J
    Q1
    VACCINE: X
    2024.
    DOI:10.1016/j.jvacx.2024.100497 (Copy DOI)
    11.
    COVIDOUTCOME-estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome
    Nagy, A;Ligeti, B;Szebeni, J;Pongor, S;Gyrffy, B
    D1
    DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION
    2021.
    DOI:10.1093/database/baab020 (Copy DOI)
    12.
    Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm
    Kozma, GT;Mészáros, T;Bakos, T;Hennies, M;Bencze, D;Uzonyi, B;Gyorffy, B;Cedrone, E;Dobrovolskaia, MA;Józsi, M;Szebeni, J
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.642860 (Copy DOI)
    13.
    Complement Activation: A Potential Threat on the Safety of Poly(ethylene glycol)-Coated Nanomedicines
    Gabizon, A;Szebeni, J
    D1
    ACS NANO
    2020.
    DOI:10.1021/acsnano.0c03648 (Copy DOI)
    Semmelweis University authors: Szebeni, János,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Transzlációs Medicina Intézet,
    14.
    Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions
    Szebeni, J;Bawa, R
    Q1
    BIOMEDICINES
    2020.
    DOI:10.3390/biomedicines8040082 (Copy DOI)
    Semmelweis University authors: Szebeni, János,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Transzlációs Medicina Intézet,
    15.
    Complement-mediated hypersensitivity reactions to an amphotericin B-containing lipid complex (Abelcet) in pediatric patients and anesthetized rats: Benefits of slow infusion
    Milosevits, G;Mészáros, T;Orfi, E;Bakos, T;Garami, M;Kovács, G;Dézsi, L;Hamar, P;Gyorffy, B;Szabó, A;Szénási, G;Szebeni, J
    D1
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
    2021.
    DOI:10.1016/j.nano.2021.102366 (Copy DOI)
    16.
    A porcine model of hemodialyzer reactions: roles of complement activation and rinsing back of extracorporeal blood
    Petho, A;Piecha, D;Mészáros, T;Urbanics, R;Moore, C;Canaud, B;Rosivall, L;Mollnes, TE;Steppan, S;Szénási, G;Szebeni, J;Dézsi, L
    Q2
    RENAL FAILURE
    2021.
    DOI:10.1080/0886022X.2021.2007127 (Copy DOI)
    17.
    Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE-/- mice
    Vigne, J;Cabella, C;Dézsi, L;Rustique, E;Couffin, AC;Aid, R;Anizan, N;Chauvierre, C;Letourneur, D;Le Guludec, D;Rouzet, F;Hyafil, F;Mészáros, T;Fülöp, T;Szebeni, J;Cordaro, A;Oliva, P;Mourier, V;Texier, I
    D1
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
    2020.
    DOI:10.1016/j.nano.2020.102157 (Copy DOI)
    18.
    Zymosan Particle-Induced Hemodynamic, Cytokine and Blood Cell Changes in Pigs: An Innate Immune Stimulation Model with Relevance to Cytokine Storm Syndrome and Severe COVID-19
    Kökeny, G;Bakos, T;Barta, BA;Nagy, GV;Mészáros, T;Kozma, GT;Szabó, A;Szebeni, J;Merkely, B;Radovits, T
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2023.
    DOI:10.3390/ijms24021138 (Copy DOI)
    19.
    Eculizumab suppresses zymosan-induced release of inflammatory cytokines IL-1a, IL-18, IFN-? and IL-2 in autologous serum-substituted PBMC cultures: Relevance to cytokine storm in Covid-19
    Bakos, T;Kozma, GT;Szebeni, J;Szénási, G
    D1
    BIOMEDICINE & PHARMACOTHERAPY
    2023.
    DOI:10.1016/j.biopha.2023.115294 (Copy DOI)
    20.
    The Hypertensive Effect of Amphotericin B-Containing Liposomes (Abelcet) in Mice: Dissecting the Roles of C3a and C5a Anaphylatoxins, Macrophages and Thromboxane
    Orfi, E;Hricisák, L;Dézsi, L;Hamar, P;Benyó, Z;Szebeni, J;Szénási, G
    Q1
    BIOMEDICINES
    2022.
    DOI:10.3390/biomedicines10071764 (Copy DOI)
    21.
    Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy
    Koller, A;Szebeni, J
    Q1
    HUMAN VACCINES & IMMUNOTHERAPEUTICS
    2023.
    DOI:10.1080/21645515.2023.2188035 (Copy DOI)
    22.
    The Critical Choice of Animal Models in Nanomedicine Safety Assessment: A Lesson Learned From Hemoglobin-Based Oxygen Carriers
    Bedocs, P;Szebeni, J
    Q1
    FRONTIERS IN IMMUNOLOGY
    2020.
    DOI:10.3389/fimmu.2020.584966 (Copy DOI)
    Semmelweis University authors: Bedőcs, Péter, Szebeni, János,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Transzlációs Medicina Intézet,
    23.
    Bioinspired orthogonal-shaped protein-biometal nanocrystals enable oral protein absorption
    Durán-Lobato, M;Tovar, S;Cuñarro, J;Ramos-Membrive, R;Peñuelas, I;Marigo, I;Benetti, F;Chenlo, M;Alvarez, C;Ildikó, V;Urbanics, R;Szebeni, J;Alonso, MJ
    D1
    JOURNAL OF CONTROLLED RELEASE
    2025.
    DOI:10.1016/j.jconrel.2024.11.016 (Copy DOI)
    Semmelweis University authors: Szebeni, János,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Transzlációs Medicina Intézet,

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_2
    Department data last refreshed at: 04.02.2025
    Author data last refreshed at: 04.02.2025
    (c) Semmelweis University - Central Library